// company-profile

Tg Therapeutics, Inc.

TGTX
ExchangeNasdaqSectorPharmaceutical PreparationsInc.DEFilings42Insiders7
// api This Tg Therapeutics, Inc. insider-trading data is served live by the Form4API insider trading API. Get the same data via API.

// activity-summary

Recent insider activity is bullish. Over the last 30 days, 5 insiders purchased shares. Buying was led by Charney Laurence N.

// 90-day insight

Over the last 90 days, Tg Therapeutics, Inc. insiders bought $0 across 5 transactions with no open-market sales.

  • Most active insider: Charney Laurence N with 1 transaction totaling $0.

Activity skews bullish — buys outpace sales.

Institutional Ownership

Top 13F-HR holders of Tg Therapeutics, Inc. as of 2026-03-31

↑ increasing
Total reported AUM
$3.26B
QoQ change
+31.9%
Reporting period
2026-03-31
#1
BlackRock, Inc.
CIK 2012383
$484.7M
14.6M shares
#2
STATE STREET CORP
CIK 93751
$287.3M
8.6M shares
#3
VANGUARD CAPITAL MANAGEMENT LLC
CIK 2100119
$219.4M
6.6M shares

Data source: SEC Form 13F-HR filings. Joined with insider activity above — see who's loading up institutionally while insiders are trading. Full 13F-HR API →

Insider Transactions

Sourced from SEC EDGAR Form 4 filings. Updated hourly.

DateInsiderCompanyTypeSharesPriceValue
Jun 11, 2026Charney Laurence NTGTX
Award
8,325$0.00$0K
Jun 11, 2026Echelard YannTGTX
Award
8,325$0.00$0K
Jun 11, 2026HUME DANIELTGTX
Award
8,325$0.00$0K
Jun 11, 2026Lonial SagarTGTX
Award
8,325$0.00$0K
Jun 11, 2026Hoberman KennethTGTX
Award
8,325$0.00$0K

45 more transactions hidden

Free account · No credit card required

Building something? Get API access →

Popular companies on Form4API

Browse insider trading activity for other actively-filed companies.